Jazz Pharmaceuticals Total Current Liabilities 2010-2024 | JAZZ
Jazz Pharmaceuticals total current liabilities for the quarter ending September 30, 2024 were $1.030B, a 34.54% decline year-over-year.
- Jazz Pharmaceuticals total current liabilities for 2023 were $1.537B, a 64.67% increase from 2022.
- Jazz Pharmaceuticals total current liabilities for 2022 were $0.933B, a 15.31% increase from 2021.
- Jazz Pharmaceuticals total current liabilities for 2021 were $0.809B, a 23.79% increase from 2020.